Moxaclav 1 gm
Moxaclav 375
Moxaclav 625
Moxaclav1.2 IV
Pylotrip
- Targeting H. pylori: Specifically formulated to eradicate H. pylori in active chronic gastric, duodenal, and gastric ulcers.
- Triple Action Pharmacology: Combines the proton-pump inhibiting power of lansoprazole with the antibacterial effects of amoxicillin and clarithromycin.
- Recommended Dosage: Advised adult dosage of one strip twice daily for 7-14 days, as directed by healthcare professionals.
- Comprehensive Gastrointestinal Care: Provides a holistic approach to gastrointestinal health with a focus on effective eradication and symptom management.
VonoKit
- Unveil the effectiveness of our triple therapy regimens, Vonokit and Vonocab Trio, meticulously crafted to combat H. pylori in chronic gastritis and ulcers.
- Harnessing the power of Vonoprazan, Amoxicillin, and Clarithromycin, these formulations are tailored to target the bacteria with precision.
- Administered orally, twice daily over a 14-day period, these medications actively suppress gastric acid production while bolstering antimicrobial stability.
- Exercise caution with potential drug interactions and contraindications, ensuring a comprehensive approach to H. pylori eradication.